If you have been diagnosed with uterine sarcoma and you have been referred to Fred Hutch Cancer Center for treatment, here are some of the treatment choices you may be offered. Remember, each woman’s ...
Uterine sarcoma - a potentially aggressive type of cancer that forms in tissues in the uterus - was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study by ...
Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a tendency toward early relapse. Survival for patients with recurrent disease is poor. In contrast, endometrial ...
Uterine sarcomas are characterised by early age at diagnosis, poor prognosis, and higher incidence among Black compared with White women, but their aetiology is poorly understood. Therefore, we ...
"Uterine sarcomas have generally been underexplored due to their rareness; nevertheless, they behave aggressively and are difficult to treat, resulting in a high clinical need," said Amant.
Uterine sarcoma -- a potentially aggressive type of cancer that forms in tissues in the uterus -- was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study ...
Between 1978, when tamoxifen was first marketed in the United States, and April 2001, there were 43 cases, reported either to the Food and Drug Administration (FDA) or in the medical literature, 1 of ...
GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and CA125. GDF15 serves as an independent prognostic factor for ...
Uterine leiomyosarcoma is difficult to distinguish from fibroids, complicating diagnosis and often requiring surgical confirmation. African American women have a doubled risk of developing uterine ...
Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a tendency toward early relapse. Survival for patients with recurrent disease is poor. In contrast, endometrial ...
Symptoms that mimic fibroids make diagnosing uterine sarcoma a rare and confounding cancer. In 2014, Dionne Shepperson, then 40 and pregnant, began feeling weak and faint. Because she had in the past ...